Elise Dumas

11PUBLICATIONS
36CO-AUTHORS
Molecular targetsEpidemiological methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 29, 2026
Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments-A VigiBase Disproportionality Analysis Study.

|Jun 27, 2025
How hazard ratios can mislead and why it matters in practice.

Elise Dumas, Mats J Stensrud

|Jun 16, 2025
Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors.

Léonard Laurent, Baptiste Abbar, Kevin Bihan

|May 29, 2025
BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase.

Aurélie Cabannes-Hamy, Rayan Kabirian, Floriane Jochum

|Mar 05, 2025
Explaining the Relationships Between Age, Endocrine Therapy Persistence, and Risk of Recurrence in Hormone Receptor-Positive Early Breast Cancer: A Nationwide Cohort Study.

Elise Dumas, Floriane Jochum, Florence Coussy

|Apr 05, 2024
Concomitant medication, comorbidity and survival in patients with breast cancer.

Elise Dumas, Beatriz Grandal Rejo, Paul Gougis

Pageof 2

Frequent Collaborators

6 joint publications

Anne-Sophie Hamy

4 joint publications

Fabien Reyal

4 joint publications

Floriane Jochum

3 joint publications

Eric Daoud